Refer a patient.

Have a patient with primary cold agglutinin disease who may be interested in the CAD Studies?

The purpose of the CAD Studies is to determine the safety and effectiveness of an investigational medication in patients with primary CAgD.

If you have a patient who may be interested and you think may qualify, refer your patient to any of the study sites listed. The research site staff will be able to answer any questions about these studies. Each patient will be required to have a visit with the study physician to evaluate if he or she qualifies. Those who qualify will receive the investigational medication or placebo, and study-related medical care at no cost to them. Any patients you refer to these studies will be seen for study-related reasons only, and, with your patient’s permission, you will have access to his or her medical records throughout the study. By referring your patients, your treating doctor status is maintained during each patient’s participation in the study.

Active SiteActive Site Location

Participating research sites.

Arizona Oncology Associates , PC- HOPE

Tucson, AZ
Contact this site 

LA, USC/Keck School of Medicine

Los Angeles, CA
Contact this site 

The Oncology Institute of Hope and Innovations

Whittier, CA
Contact this site 

MedStart Georgetown University Hospital

Washington, DC
Contact this site 

Massachusetts General Hospital

Boston, MA
Contact this site 

East Carolina University

Greenville, NC
Contact this site 

Medical Oncology & Hematology

Bronx, NY
Contact this site 

Westchester Medical Center

Hawthrone, NY
Contact this site 

Cleveland Clinic, Taussig Cancer Center

Cleveland, OH
Contact this site 

Hopsital of the University of Pennsylvania

Philadelphia, PA
Contact this site 

UPMC Hillman Cancer Center

Pittsburgh, PA
Contact this site 

University of Wisconsin Hospitals & Clinics

Madison, WI
Contact this site